Patients Drive Authentic Trusted Solutions for Inclusive Clinical Trials

Cancer clinical trials remain highly underrepresented from racial and ethnic minorities. The lack of diversity in clinical trials significantly impacts the generalizability of drug treatments approved for cancer patients. This review intends to discuss recent shifts in cancer clinical trials to increase equitable participation across all patient populations.

Current trends highlight innovative ways to build accessible clinical trials with diverse patient populations in mind. Patient-driven technology in the form of digital health platforms was created to address the gap in financial and non-financial barriers to clinical trial participation.

Recent research sheds light on ways to make clinical trials more accessible to patients. This review will showcase how clinical trial site leaders, coordinators, and sponsors can meet the needs of patients to ensure they can participate in future clinical trials by engaging with community leaders and patient organizations.